Frontlight ResearchEarly access
Psoriatic arthritis trials in United Kingdom
8 of 12 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Stoke-on-Trent
- Age
- 18 years and over
- People
- 1,182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - Phase 3Taking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Bristol, Liverpool, London, Oxford, Sheffield
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 · EU 2023-506131-15-00 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Sheffield, Stoke-on-Trent
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Bristol, Manchester, Nottingham, Stoke-on-Trent
- Age
- 2 years to 18 years
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - Phase 3Taking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Birmingham, Liverpool, Nottingham, Oxford
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - Phase 3Taking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Bristol, Liverpool, Sheffield
- Age
- 5 years to 17 years
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseTaking peopleCombination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Where
- Birmingham, Coventry, Glasgow, Newcastle upon Tyne
- Age
- 18 years to 75 years
- People
- 45
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07443956 - No phaseNot yet taking people in United KingdomRewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
- Where
- Glasgow
- Age
- 18 years to 75 years
- People
- 40
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07403890